Lv5
1470 积分 2024-07-02 加入
Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity
1个月前
已完结
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
1个月前
已完结
Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression
1个月前
已完结
Association between depression subtypes and response to repeated‐dose intravenous ketamine
2个月前
已完结
Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale
2个月前
已完结
Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders
2个月前
已完结
Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature
2个月前
已完结
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
2个月前
已完结
Ketamine specifically reduces cognitive symptoms in depressed patients: An investigation of associated neural activation patterns
2个月前
已完结
The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation?
2个月前
已完结
皖公网安备34019202002308
